Filtrer vos résultats
- 3
- 3
- 3
- 1
- 2
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinomaOncotarget, 2018, 9 (39), pp.25617-25629. ⟨10.18632/oncotarget.25424⟩
Article dans une revue
hal-01821601v1
|
||
|
Antibiotic Use Does Not Appear to Influence Response to Nivolumab.Anticancer Research, 2017, 37 (6), pp.3195-3200. ⟨10.21873/anticanres.11680⟩
Article dans une revue
hal-01545832v1
|
||
|
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancerOncoImmunology, 2017, 6 (9), pp.e1339856. ⟨10.1080/2162402X.2017.1339856⟩
Article dans une revue
hal-01694057v1
|